Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

06 Aug 2018 Evaluate

Alembic Pharmaceutical has informed about press release that the company received US Food & Drug Administration (USFDA) Tentative Approval for Bimatoprost Ophthalmic Solution, 0.03%.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..